These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29214413)

  • 1. New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.
    Shield KD; Marant Micallef C; de Martel C; Heard I; Megraud F; Plummer M; Vignat J; Bray F; Soerjomataram I
    Eur J Epidemiol; 2018 Mar; 33(3):263-274. PubMed ID: 29214413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population attributable fraction of infection-related cancers in Korea.
    Shin A; Park S; Shin HR; Park EH; Park SK; Oh JK; Lim MK; Choi BY; Boniol M; Boffetta P
    Ann Oncol; 2011 Jun; 22(6):1435-1442. PubMed ID: 20974652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of cancers attributable to infections in 2012: a synthetic analysis.
    Plummer M; de Martel C; Vignat J; Ferlay J; Bray F; Franceschi S
    Lancet Glob Health; 2016 Sep; 4(9):e609-16. PubMed ID: 27470177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancers attributable to infections in Canada.
    Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
    Prev Med; 2019 May; 122():109-117. PubMed ID: 31078164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.
    de Martel C; Ferlay J; Franceschi S; Vignat J; Bray F; Forman D; Plummer M
    Lancet Oncol; 2012 Jun; 13(6):607-15. PubMed ID: 22575588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/Ethnic Differences in Cancers Attributable to Preventable Infectious Agents in Texas, 2015.
    Gudenkauf FJ; Thrift AP
    Public Health Rep; 2020; 135(6):805-812. PubMed ID: 33080142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Cancer Burden Attributable to Infection in Asia.
    Huang H; Hu XF; Zhao FH; Garland SM; Bhatla N; Qiao YL
    J Epidemiol; 2015; 25(10):626-38. PubMed ID: 26399446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancers in Australia in 2010 attributable to infectious agents.
    Antonsson A; Wilson LF; Kendall BJ; Bain CJ; Whiteman DC; Neale RE
    Aust N Z J Public Health; 2015 Oct; 39(5):446-51. PubMed ID: 26437730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cancer burden attributable to biologic agents.
    Schottenfeld D; Beebe-Dimmer J
    Ann Epidemiol; 2015 Mar; 25(3):183-7. PubMed ID: 25523895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in Africa 2018: The role of infections.
    Parkin DM; Hämmerl L; Ferlay J; Kantelhardt EJ
    Int J Cancer; 2020 Apr; 146(8):2089-2103. PubMed ID: 31254479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
    de Martel C; Georges D; Bray F; Ferlay J; Clifford GM
    Lancet Glob Health; 2020 Feb; 8(2):e180-e190. PubMed ID: 31862245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of the future burden of cancer attributable to infections in Canada.
    Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
    Prev Med; 2019 May; 122():118-127. PubMed ID: 31078165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can we prevent or cure infection-related cancers?].
    Gisserot O; Romeo E; Boudin L; Tsitsi Nding Tsogou P; Abed S; Bladé JS; de Jauréguiberry JP
    Rev Med Interne; 2014 Apr; 35(4):259-63. PubMed ID: 24359725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.
    DE Flora S; LA Maestra S; Crocetti E; Mangone L; Bianconi F; Stracci F; Buzzoni C
    J Prev Med Hyg; 2019 Dec; 60(4):E311-E326. PubMed ID: 31967088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancers attributable to infectious agents in Italy.
    Collatuzzo G; La Vecchia C; Parazzini F; Alicandro G; Turati F; Di Maso M; Malvezzi M; Pelucchi C; Negri E; Boffetta P
    Eur J Cancer; 2023 Apr; 183():69-78. PubMed ID: 36801622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.
    Hartwig S; Syrjänen S; Dominiak-Felden G; Brotons M; Castellsagué X
    BMC Cancer; 2012 Jan; 12():30. PubMed ID: 22260541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global health burden of infection-associated cancers in the year 2002.
    Parkin DM
    Int J Cancer; 2006 Jun; 118(12):3030-44. PubMed ID: 16404738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Evidence for Infectious Causes of Cancer in the United States.
    Brown HE; Dennis LK; Lauro P; Jain P; Pelley E; Oren E
    Epidemiol Rev; 2019 Jan; 41(1):82-96. PubMed ID: 32294189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of infection-associated cancers in Italy and prevention strategies.
    De Flora S; Crocetti E; Bonanni P; Ferro A; Vitale F;
    Epidemiol Prev; 2015; 39(4 Suppl 1):14-20. PubMed ID: 26499410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancers Attributable to Infections in the US in 2017: A Meta-Analysis.
    Volesky-Avellaneda KD; Morais S; Walter SD; O'Brien TR; Hildesheim A; Engels EA; El-Zein M; Franco EL
    JAMA Oncol; 2023 Dec; 9(12):1678-1687. PubMed ID: 37856141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.